Calculated Parenteral Initial Therapy of Bacterial Infections: Bacterial Meningitis

Overview

Journal GMS Infect Dis

Specialty Infectious Diseases

Date 2020 May 7

PMID 32373432

Citations 1

Authors

Pramod M Shah

Reinhard Brodt

Thomas A Wichelhaus

Roland Nau

Affiliations

Soon will be listed here.

Abstract

This is the thirteenth chapter of the guideline "Calculated initial parenteral treatment of bacterial infections in adults - update 2018" in the 2 updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Bacterial meningitis is a life-threatening infectious disease with high mortality and disability rates requiring prompt initiation of antimicrobial treatment to lower these rates.

Citing Articles

S2k guideline "Calculated parenteral initial treatment of bacterial infections in adults - update 2018", 2 updated version: Foreword.

Bodmann K, Grabein B, Kresken M GMS Infect Dis. 2020; 8:Doc20.

PMID: 32373445 PMC: 7186796. DOI: 10.3205/id000064.

References

Reiber H, Lange P . Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem. 1991; 37(7):1153-60. View

Thwaites G, Nguyen D, Nguyen H, Hoang T, Do T, Nguyen T . Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004; 351(17):1741-51. DOI: 10.1056/NEJMoa040573. View

Prasad K, Singh M . Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2008; (1):CD002244. DOI: 10.1002/14651858.CD002244.pub3. View

Auburtin M, Wolff M, Charpentier J, Varon E, Le Tulzo Y, Girault C . Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med. 2006; 34(11):2758-65. DOI: 10.1097/01.CCM.0000239434.26669.65. View

Glimaker M, Johansson B, Grindborg O, Bottai M, Lindquist L, Sjolin J . Adult bacterial meningitis: earlier treatment and improved outcome following guideline revision promoting prompt lumbar puncture. Clin Infect Dis. 2015; 60(8):1162-9. DOI: 10.1093/cid/civ011. View

Durand M, Calderwood S, Weber D, MILLER S, Southwick F, Caviness Jr V . Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993; 328(1):21-8. DOI: 10.1056/NEJM199301073280104. View

Sousa D, Llinares P, Meijide H, Gutierrez J, Miguez E, Sanchez E . Clinical experience with linezolid for the treatment of neurosurgical infections. Rev Esp Quimioter. 2011; 24(1):42-7. View

Brouwer M, van de Beek D . Earlier Treatment and Improved Outcome in Adult Bacterial Meningitis Following Guideline Revision Promoting Prompt Lumbar Puncture. Clin Infect Dis. 2015; 61(4):664-5. DOI: 10.1093/cid/civ328. View

Skoczynska A, Alonso J, Taha M . Ciprofloxacin resistance in Neisseria meningitidis, France. Emerg Infect Dis. 2008; 14(8):1322-3. PMC: 2600386. DOI: 10.3201/eid1408.080040. View

10.

Marcos M, Martinez E, Almela M, Mensa J, Jimenez de Anta M . New rapid antigen test for diagnosis of pneumococcal meningitis. Lancet. 2001; 357(9267):1499-500. DOI: 10.1016/s0140-6736(00)04658-4. View

11.

Bohr V, Hansen B, JESSEN O, Johnsen N, Kjersem H, KRISTENSEN H . Eight hundred and seventy-five cases of bacterial meningitis. Part I of a three-part series: clinical data, prognosis, and the role of specialised hospital departments. J Infect. 1983; 7(1):21-30. DOI: 10.1016/s0163-4453(83)90894-0. View

12.

Nau R, Sorgel F, Eiffert H . Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010; 23(4):858-83. PMC: 2952976. DOI: 10.1128/CMR.00007-10. View

13.

Fraser A, Gafter-Gvili A, Paul M, Leibovici L . Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev. 2006; (4):CD004785. DOI: 10.1002/14651858.CD004785.pub3. View

14.

Lange C, Abubakar I, Alffenaar J, Bothamley G, Caminero J, Carvalho A . Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J. 2014; 44(1):23-63. PMC: 4076529. DOI: 10.1183/09031936.00188313. View

15.

Rupprecht T, Pfister H . Clinical experience with linezolid for the treatment of central nervous system infections. Eur J Neurol. 2005; 12(7):536-42. DOI: 10.1111/j.1468-1331.2005.01001.x. View

16.

Alcala B, Salcedo C, de la Fuente L, Arreaza L, Uria M, Abad R . Neisseria meningitidis showing decreased susceptibility to ciprofloxacin: first report in Spain. J Antimicrob Chemother. 2004; 53(2):409. DOI: 10.1093/jac/dkh075. View

17.

Singhal S, Purnapatre K, Kalia V, Dube S, Nair D, Deb M . Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India. Emerg Infect Dis. 2008; 13(10):1614-6. PMC: 2851515. DOI: 10.3201/eid1310.060820. View

18.

Mourvillier B, Tubach F, van de Beek D, Garot D, Pichon N, Georges H . Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA. 2013; 310(20):2174-83. DOI: 10.1001/jama.2013.280506. View

19.

Peltola H, Anttila M, RENKONEN O . Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Lancet. 1989; 1(8650):1281-7. DOI: 10.1016/s0140-6736(89)92685-8. View

20.

Schaberg T, Bauer T, Brinkmann F, Diel R, Feiterna-Sperling C, Haas W . [Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)]. Pneumologie. 2017; 71(6):325-397. DOI: 10.1055/s-0043-105954. View